Citigroup Initiates Coverage On Korro Bio with Buy Rating, Announces Price Target of $21
Benzinga Newsdesk 5 months ago
NewsPrice TargetInitiationAnalyst Ratings
Citigroup analyst Yigal Nochomovitz initiates coverage on Korro Bio (NASDAQ:KRRO) with a Buy rating and announces Price Target of $21.
Citigroup analyst Yigal Nochomovitz initiates coverage on Korro Bio (NASDAQ:KRRO) with a Buy rating and announces Price Target of $21.